Description
Survodutide is part of our Metabolic Research range. Every order is a kit of 10 vials.
Class of compound
Peptide (dual GLP-1 and glucagon receptor agonist)
Mechanism of action
Activates GLP-1 receptors (appetite and insulin) and glucagon receptors (energy use and liver fat).
Potential benefits studied
- Body weight
- Liver fat (MASH research)
Who should not use it
- Anyone under 18
- Anyone pregnant, breastfeeding or trying to conceive
- Anyone with a known allergy to this compound
- Anyone with a medical condition or taking medication, unless a doctor has advised it
- Personal or family history of medullary thyroid carcinoma (MTC) or MEN 2
- History of pancreatitis or gallbladder disease
- Type 1 diabetes, or severe gastrointestinal disease such as gastroparesis
- Anyone taking insulin or other glucose-lowering medicines without medical supervision
What to expect
Human trials reported weight reduction and liver fat improvements, with GI side effects. Not yet approved.
Available sizes
5mg (10 vials) / 10mg (10 vials)
Questions about this product? Message us on WhatsApp and a real person will reply. We do not give dosing or medical advice.
Research use only. Not for human consumption. The information above summarises published research for educational purposes only. It is not medical advice and has not been evaluated by any regulatory authority. Always do your own research and speak with a qualified healthcare professional.









There are no reviews yet.